108 related articles for article (PubMed ID: 15138581)
1. Cell cycle-dependent transcriptional regulation of calmodulin-binding transcription activator 1 in neuroblastoma cells.
Nakatani K; Nishioka J; Itakura T; Nakanishi Y; Horinouchi J; Abe Y; Wada H; Nobori T
Int J Oncol; 2004 Jun; 24(6):1407-12. PubMed ID: 15138581
[TBL] [Abstract][Full Text] [Related]
2. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.
Henrich KO; Bauer T; Schulte J; Ehemann V; Deubzer H; Gogolin S; Muth D; Fischer M; Benner A; König R; Schwab M; Westermann F
Cancer Res; 2011 Apr; 71(8):3142-51. PubMed ID: 21385898
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23.
Katoh M; Katoh M
Int J Oncol; 2003 Oct; 23(4):1219-24. PubMed ID: 12964007
[TBL] [Abstract][Full Text] [Related]
4. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
[TBL] [Abstract][Full Text] [Related]
6. Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma.
Henrich KO; Claas A; Praml C; Benner A; Mollenhauer J; Poustka A; Schwab M; Westermann F
Eur J Cancer; 2007 Feb; 43(3):607-16. PubMed ID: 17222547
[TBL] [Abstract][Full Text] [Related]
7. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
Spengler BA; Lazarova DL; Ross RA; Biedler JL
Oncol Res; 1997; 9(9):467-76. PubMed ID: 9495452
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
Takahashi M; Ozaki T; Todo S; Nakagawara A
Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
[TBL] [Abstract][Full Text] [Related]
9. Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance.
Huentelman MJ; Papassotiropoulos A; Craig DW; Hoerndli FJ; Pearson JV; Huynh KD; Corneveaux J; Hänggi J; Mondadori CR; Buchmann A; Reiman EM; Henke K; de Quervain DJ; Stephan DA
Hum Mol Genet; 2007 Jun; 16(12):1469-77. PubMed ID: 17470457
[TBL] [Abstract][Full Text] [Related]
10. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of calcyclin, a gene with strong homology to S-100 protein, during neuroblastoma cell differentiation and its prevalent expression in Schwann-like cell lines.
Tonini GP; Casalaro A; Cara A; Di Martino D
Cancer Res; 1991 Mar; 51(6):1733-7. PubMed ID: 1998963
[TBL] [Abstract][Full Text] [Related]
12. Expression of the smg p25A (a ras p21-like GTP-binding protein) gene in human neuroblastoma cell lines and tumor tissues.
Sano K; Nakamura H; Mabuchi S; Tanaka T; Nakagawara A; Takai Y
Cancer Res; 1990 Nov; 50(22):7242-5. PubMed ID: 2121331
[TBL] [Abstract][Full Text] [Related]
13. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.
Welch C; Chen Y; Stallings RL
Oncogene; 2007 Jul; 26(34):5017-22. PubMed ID: 17297439
[TBL] [Abstract][Full Text] [Related]
15. Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells.
Gentilella A; Passiatore G; Deshmane S; Turco MC; Khalili K
Oncogene; 2008 Aug; 27(37):5011-8. PubMed ID: 18469860
[TBL] [Abstract][Full Text] [Related]
16. Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells.
Louhivuori LM; Bart G; Larsson KP; Louhivuori V; Näsman J; Nordström T; Koivisto AP; Akerman KE
J Cell Physiol; 2009 Oct; 221(1):67-74. PubMed ID: 19507192
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
18. The calcium-sensing receptor and parathyroid hormone-related protein are expressed in differentiated, favorable neuroblastic tumors.
de Torres C; Beleta H; Díaz R; Toran N; Rodríguez E; Lavarino C; García I; Acosta S; Suñol M; Mora J
Cancer; 2009 Jun; 115(12):2792-803. PubMed ID: 19350667
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of regucalcin suppresses cell proliferation in cloned rat hepatoma H4-II-E cells: involvement of intracellular signaling factors and cell cycle-related genes.
Yamaguchi M; Daimon Y
J Cell Biochem; 2005 Aug; 95(6):1169-77. PubMed ID: 15962315
[TBL] [Abstract][Full Text] [Related]
20. Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma.
Molenaar JJ; van Sluis P; Boon K; Versteeg R; Caron HN
Genes Chromosomes Cancer; 2003 Mar; 36(3):242-9. PubMed ID: 12557224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
